Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815899) titled 'Effects of Peppermint Oil in Pre-metabolic Syndrome' on Sept. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: University of Central Lancashire

Condition: Pre-metabolic Syndrome

Intervention: Dietary Supplement: Peppermint Oil

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: January 1, 2025

Target Sample Size: 40

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/study/NCT07815899

Published by...